Intracerebral Hemorrhage Surgical Devices Sector: Growth Drivers and Challenges
Growth Drivers
- Increasing Cases of Intracerebral Hemorrhage
- Growing R&D Activities in the Medical Field
Challenges
- Postsurgical Complications
- High Cost of Surgery
Intracerebral Hemorrhage Surgical Devices Market: Key Insights
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
6.7% |
|
Base Year Market Size (2024) |
USD 1.82 billion |
|
Forecast Year Market Size (2037) |
USD 4.23 billion |
|
Regional Scope |
|
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of intracerebral hemorrhage surgical devices is evaluated at USD 1.92 billion.
Intracerebral Hemorrhage Surgical Devices Market size was over USD 1.82 billion in 2024 and is poised to exceed USD 4.23 billion by 2037, growing at over 6.7% CAGR during the forecast period i.e., between 2025-2037.
North America industry is expected to dominate majority revenue share by 2037, on the back of rising healthcare expenditure and investment in R&D activities, along with the presence of major market players in the region.
The major players in the market are Stryker Corporation, Abbott Laboratories, General Electric Company, Johnson & Johnson Services, Inc., Terumo Corporation, Becton, Dickinson and Company, and others.
